- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 4/00 - Peptides having up to 20 amino acids in an undefined or only partially defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 4/00
Total number of patents in this class: 450
10-year publication summary
|
39
|
26
|
32
|
30
|
21
|
7
|
18
|
15
|
18
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19868 |
13 |
| Ambrx, Inc. | 181 |
6 |
| Emulate, Inc. | 221 |
6 |
| The University of Chicago | 1400 |
5 |
| Centre National de La Recherche Scientifique | 10414 |
4 |
| The United States of America as represented by the Secretary of the Navy | 2747 |
4 |
| The Regents of the University of Michigan | 4685 |
4 |
| President and Fellows of Harvard College | 5966 |
4 |
| Duke University | 3066 |
4 |
| Aileron Therapeutics, Inc. | 80 |
4 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2148 |
4 |
| Genequantum Healthcare (Suzhou) Co., Ltd. | 62 |
4 |
| FUJIFILM Corporation | 29305 |
3 |
| Idemitsu Kosan Co., Ltd. | 4212 |
3 |
| The General Hospital Corporation | 4720 |
3 |
| Ajinomoto Co., Inc. | 2305 |
3 |
| Agency for Science, Technology and Research | 3604 |
3 |
| The Board of Trustees of the University of Illinois | 2689 |
3 |
| AC Immune S.A. | 260 |
3 |
| bioMerieux | 922 |
3 |
| Other owners | 364 |